Association between M1 and M2 macrophages in bronchoalveolar lavage fluid and tobacco smoking in patients with sarcoidosis

Polskie Archiwum Medycyny Wewnetrznej

Volumn 124, Issue 7-8, 2014, Pages 359-364

  Osińska, Iwona ^a   Wołosz, Dominika ^a   Domagała Kulawik, Joanna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Alveolar macrophages; Bronchoalveolar lavage; CD163; CD40; Sarcoidosis

Indexed keywords

CD163 ANTIGEN; CD40 ANTIGEN; CELL ANTIBODY; INTERLEUKIN 10; AUTACOID; BIOLOGICAL MARKER; CYTOKINE;

ADULT; AGED; ARTICLE; CELL POLARITY; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIMIT OF DETECTION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG SARCOIDOSIS; M1 MACROPHAGE; M2 MACROPHAGE; MALE; POLARIZATION; SMOKING; STAINING; BRONCHOALVEOLAR LAVAGE FLUID; COMPARATIVE STUDY; IMMUNOLOGY; MACROPHAGE; MIDDLE AGED; PATHOLOGY; SMOKING CESSATION;

ADULT; BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; MIDDLE AGED; SARCOIDOSIS, PULMONARY; SMOKING; SMOKING CESSATION;

EID: 84906858948     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2339     Document Type: Article

References (38)

1. Fernandez Fabrellas E. Epidemiology of sarcoidosis. Arch Bronconeumol. 2007; 43: 92-100. (Pubitemid 46374299)
2. Dubaniewicz A. [Sarcoidosis - a disease with many faces]. Forum Medycyny Rodzinnej. 2009; 3: 27-41. Polish.
3. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007; 357: 2153-2165.
4. Rowińska-Zakrzewska E, Bestry I. [Interstitial lung diseases]. In: Szczeklik A, ed. [Internal diseases]. Kraków, Poland: Medycyna Praktyczna; 2011: 644-648. Polish.
5. Dubaniewicz A, Typiak M, Wybieralska M, et al. Changed phagocytic activity and pattern of Fcgamma and complement receptors on blood monocytes in sarcoidosis. Hum Immunol. 2012; 73: 788-794.
6. Morgenthau AS, Iannuzzi MC. Recent advances in sarcoidosis. Chest. 2011; 139: 174-182.
7. Domagala-Kulawik J. Effects of cigarette smoke on the lung and systemic immunity. J Physiol Pharmacol. 2008; 59 (Suppl 6): 19-34.
8. Soler P, Basset F. Morphology and distribution of the cells of a sarcoid granuloma: ultrastructural study of serial sections. Ann N Y Acad Sci. 1976; 278: 147-160.
9. Muller-Quernheim J, Pfeifer S, Mannel D, et al. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis. 1992; 145: 187-192.
10. Ziegenhagen MW, Muller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J Intern Med. 2003; 253: 18-30. (Pubitemid 36120994)
11. Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. ScientificWorldJournal. 2011; 11: 2391-2402.
12. Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23: 549-555. (Pubitemid 35223554)
13. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008; 8: 958-969.
14. Locati M, Otero K, Schioppa T, et al. The chemokine system: tuning and shaping by regulation of receptor expression and coupling in polarized responses. Allergy. 2002; 57: 972-982. (Pubitemid 35238633)
15. Aron-Wisnewsky J, Tordjman J, Poitou C, et al. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab. 2009; 94: 4619-4623.
16. Kunz LI, Lapperre TS, Snoeck-Stroband JB, et al. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD. Respir Res. 2011;12: 34.
17. Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001; 19: 683-765. (Pubitemid 32368050)
18. Mantovani A. Macrophage diversity and polarization: in vivo veritas. Blood. 2006; 108: 408-409. (Pubitemid 44061327)
19. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11: 889-896.
20. Douglas JG, Middleton WG, Gaddie J, et al. Sarcoidosis: a disorder commoner in non-smokers? Thorax. 1986; 41: 787-791. (Pubitemid 16020228)
21. Valeyre D, Soler P, Clerici C, et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax. 1988; 43: 516-524.
22. Chcialowski A, Chorostowska-Wynimko J, Fal A, et al. Recommendation of the Polish Respiratory Society for bronchoalveolar lavage (BAL) sampling, processing and analysis methods. Pneumonol Alergol Pol. 2011; 79: 75-89.
23. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999; 160: 736-755.
24. Drent M, Mansour K, Linssen C. Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med. 2007; 28: 486-495. (Pubitemid 350036959)
25. Urbankowski T, Knyziak-Medrzycka I, Domagala-Kulawik J, et al. Sarcoidosis and tobacco smoking- clinical picture, diagnostic tests results and bronchoalveolar lavage fluid composition. Pol Merkur Lekarski. 2012; 32: 298-301.
26. Hance AJ, Basset F, Saumon G, et al. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci. 1986; 465: 643-656. (Pubitemid 16006604)
27. Harf RA, Ethevenaux C, Gleize J, et al. Reduced prevalence of smokers in sarcoidosis. Results of a case-control study. Ann N Y Acad Sci. 1986; 465: 625-631. (Pubitemid 16006602)
28. Hodge S, Hodge G, Ahern J, et al. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2007; 37: 748-755. (Pubitemid 350211645)
29. Mancini NM, Bene MC, Gerard H, et al. Early effects of short-time cigarette smoking on the human lung: a study of bronchoalveolar lavage fluids. Lung. 1993; 171: 277-291. (Pubitemid 23251258)
30. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002; 2: 372-377. (Pubitemid 37328760)
31. Skold CM LJ, Hallden G, Hallgren M, Eklund A. Chronic smoke exposure alters the phenotype pattern and the metabolic response in human alveolar macrophages. Clin Exp Immunol. 1996; 106: 108-113. (Pubitemid 26329388)
32. Urbankowski T, Hoser G, Domagala-Kulawik J. Th1/Th2/Th17related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis: association with smoking. Pol Arch Med Wewn. 2012; 122: 320-325.
33. Domagala-Kulawik J, Urbankowski T, Safianowska A. S Fas in bronchoalveolar lavage fluid of patients with sarcoidosis in relation to cigarette smoking. Hum Immunol. 2013; 74: 858-860.
34. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med. 2001; 7: 255-261. (Pubitemid 32929679)
35. Imaizumi K, Kawabe T, Ichiyama S, et al. Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction. Am J Physiol. 1999; 277: 49-57.
36. Wikén M, Idali F, Al Hayja MA, et al. No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis. Respir Res. 2010; 11: 121.
37. Prokop S, Heppner FL, Goebel HH, et al. M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis. Am J Pathol. 2011; 178: 1279-1286.
38. Kowal K, Silver R, Slawinska E, et al. CD163 and its role in inflammation. Folia Histochem Cytobiol. 2011; 49: 365-374.